Mr Arthur Robinson > Simpson Thacher & Bartlett LLP > New York, United States > Lawyer Profile

Simpson Thacher & Bartlett LLP remains an established leader in DCM, with an outstanding record in investment grade debt, high-yield debt, convertible bonds, equity-linked instruments and derivatives transactions. It is equally highly-rated for both issuer and underwriter engagements. The New York-based team has a fine background in representing first-time issuers and repeat issuers thanks to its expertise in high-yield debt and IPOs. In 2022, it continued to advise on a series of bulge-bracket and headline deals, including representing the underwriters in two public offerings by UnitedHealth Group totalling $15bn. It also advised the initial purchasers and selling security holders in AT&T’s $30bn senior notes offering in connection with the combination of WarnerMedia with Discovery. Kenneth Wallach is an experienced capital markets specialist with a fine record in investment grade debt and convertible bond offerings. Roxane Reardon is rated for investment grade debt, convertible debt and equity-linked securities. Ryan Bekkerus and John Ericson are also key partners. The seasoned Arthur Robinson retains an outstanding reputation.

Despite having a smaller capital markets team than many of its direct rivals, Simpson Thacher & Bartlett LLP is a longstanding leader in high-yield debt, both for issuers and underwriters. The firm – which is at the forefront of leveraged finance and standalone high-yield debt transactions – represents many of the marquee private equity houses in the market, along with their portfolio companies. It also boasts an extensive public company and underwriter client base, and is noted for ESG and sustainability-linked offerings and for representing issuers moving towards investment grade status. Kenneth Wallach is a leading figure in private equity-related deals and technology sector transactions. Arthur Robinson is a seasoned capital markets specialist with rich pedigree in high-yield debt, including in the healthcare sector. John Ericson and David Azarkh are also key figures in the team. Named partners are based in New York.